Fred B. Craves
Director · MADRIGAL PHARMACEUTICALS, INC.
- 2024
- Dec 5, 2024
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Fred B. Craves files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- William John Sibold - $10.48M in MDGL purchases and sales in the last 12 months
- Kenneth Bate - $8.03M in MDGL purchases and sales in the last 12 months
- Richard S. Levy - $7.36M in MDGL purchases and sales in the last 12 months
- Mardi Dier - $3.77M in MDGL purchases and sales in the last 12 months
- Carole Huntsman - $1.71M in MDGL purchases and sales in the last 12 months
- Rebecca Taub - $1.63M in MDGL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Fred B. Craves?
Fred B. Craves is a corporate insider, tracked as Director of MADRIGAL PHARMACEUTICALS, INC. (MDGL). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Fred B. Craves last file a Form 4?
The most recent primary Form 4 on record is dated 5 December 2024, one of 2 filings going back to 2024.
Has Fred B. Craves been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($2.33M) across all tracked filings.
